Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Am J Manag Care. 2014 Nov;20(11):e498–e505.

Table 4.

Odds Ratios of Fully Adherent Among Beneficiaries with a Heart-Disease Related Readmission Relative to Those Without a Readmission, Results from Logistic Regressions

Odds Ratio Std. Error 95% CI
First Readmission Occurring During 6-9 Months Post-MI Discharge
MPR >=0.75 for All MI Drugs 0.79 0.02 (0.75, 0.83)
MPR >=0.75 for β-Blockers 0.83 0.03 (0.79, 0.89)
MPR >=0.80 for All MI Drugs 0.78 0.02 (0.74, 0.83)
MPR >=0.80 for β-Blockers 0.84 0.03 (0.79, 0.89)
First Readmission Occurring During 9-12 Months Post-MI Discharge
MPR >=0.75 for All MI Drugs 0.74 0.02 (0.70, 0.79)
MPR >=0.75 for β-Blockers 0.81 0.03 (0.75, 0.87)
MPR >=0.80 for All MI Drugs 0.73 0.02 (0.68, 0.77)
MPR >=0.80 for β-Blockers 0.79 0.03 (0.74, 0.85)

Notes: The dependent variable is the indicator for good adherence – we tested separately for MPR≥0.8 and MPR≥0.75. The covariates include individual-level characteristics for demographic, insurance coverage, and health status, as well as ZIP Code level income and education (see the Adjustment Variables section).